Skip to main navigation

Work With Us
Contact

Home
About Us
Science
- Publications
Pipeline
UBX1325
Clinical Trials
Investors & Media
Work With Us
Contact
Menu

Events & Presentations

Corporate Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
- Contact IR
- Investor FAQs

Investor Tools

Print Page
Email Page
Contact IR
Email Alerts
RSS Feeds

Latest Presentation

Corporate Presentation August 2024

August 8, 2024

Effect of Patient Baseline Characteristics on Response to UBX1325, a Novel Senolytic Candidate For Patients With DME: BEHOLD Phase 2 Study 48 weeks follow-up

May 6, 2024

ARVO 2024, Presented by Dante Pieramici, M.D.

48-Week End of Study Results from BEHOLD Phase 2 Study of UBX1325 in Patients with DME

October 6, 2023

EURETINA 2023, Presented by Veeral Sheth, M.D., M.B.A., F.A.C.S., FASRS

Upcoming Events

There are no upcoming events available at this time.

Past Events

H.C. Wainwright 26th Annual Global Investment Conference

September 9, 2024 7:00 AM EDT

Click here for webcast

H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

August 15, 2024 7:00 AM EDT

Click here for webcast

©2024 Unity Biotechnology. All Rights Reserved.

Terms & Conditions |
Privacy Policy